Quantcast
Last updated on April 19, 2014 at 9:20 EDT

Latest Rhinitis Stories

2012-05-03 06:27:01

LANCASTER, Pa. and ROCKVILLE, Md., May 3, 2012 /PRNewswire/ -- Immunomic Therapeutics, Inc., ("ITI," Lancaster, PA) a privately-held biotechnology company with laboratories in Rockville, MD, announced that the U.S. Food and Drug Administration (FDA) has completed its review of the Investigational New Drug Application ("IND") filed for the allergy immunotherapy, JRC- LAMP-vax((TM)). On April 12th, the FDA notified ITI that there will be no clinical hold and that ITI may now proceed...

2012-04-19 23:02:47

A new Henry Ford Hospital study shows mood disorders are not linked to either nasal obstructive symptoms or the failure of nasal obstruction surgery. Detroit, Michigan (PRWEB) April 19, 2012 While mood disorders like depression or anxiety tend to negatively affect treatment for allergies and chronic rhinosinusitis, the same cannot be said for patients with nasal obstructions such as deviated septum, according to researchers at Henry Ford Hospital. The new study shows mood disorders are not...

2012-04-19 21:10:05

While mood disorders like depression or anxiety tend to negatively affect treatment for allergies and chronic rhinosinusitis, the same cannot be said for patients with nasal obstructions such as deviated septum, according to researchers at Henry Ford Hospital. The new study shows mood disorders are not linked to either nasal obstructive symptoms or the failure of nasal obstruction surgery. Results also suggest that those patients with nasal obstruction caused by septal deviation —...

2012-04-11 02:25:00

HORSHAM, Pa., April 11, 2012 /PRNewswire/ -- Teva Respiratory and the Asthma and Allergy Foundation of America (AAFA) announced today the launch of a national awareness campaign - Ditch the Drip, Get Serious about Nasal Allergies - aimed at raising awareness of the seriousness of seasonal and year-round allergies and the need for people living with nasal allergies to adequately prepare for their peak allergy seasons. The program features two-time Olympic volleyball gold medalist and seasonal...

2012-03-20 06:26:39

LEIDEN, The Netherlands, March 20, 2012 /PRNewswire/ -- HAL Allergy B.V. today announced that it has successfully completed patient enrollment in its Phase II dose range finding study. This multi-centre, randomized, double-blind, placebo-controlled study in 250 patients with persistent allergic rhinitis / rhinoconjunctivitis will characterize the dose-response relationship of PURETHAL(R) Mites in order to support the optimal dose in terms of clinical efficacy and safety....

2012-03-19 18:20:13

Allergy Foundation Releases New "Spring Allergy Capital" Rankings, Knoxville is #1 WASHINGTON, March 20, 2012 /PRNewswire-USNewswire/ -- Today is the vernal equinox - otherwise known as the official end of winter and the start of spring. But even if you didn't look at your calendar today, chances are your nose already figured it out. That's because more than 40 million Americans have nasal allergies (also called, allergic rhinitis or "hay fever"). Springtime allergy triggers -...

2012-03-14 04:00:00

DUBAI, UAE, March 14, 2012 /PRNewswire/ -- - United Arab Emirates is the First Country in the Middle East to Introduce Omnaris(R) to Region's Allergy Sufferers - Nycomed, a Takeda company, today announced that Omnaris(R) (ciclesonide) Nasal Spray is now available in the United Arab Emirates for the treatment of allergic rhinitis, also known as nasal allergies and hay fever, in adults and adolescents over the age of 12. Omnaris(R) Nasal Spray is a long-lasting...

2012-03-08 03:00:00

OXFORD, England, March 8, 2012 /PRNewswire/ -- Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that its ragweed allergy therapy has achieved positive results in a key phase II clinical trial. In the study, patients with more severe symptoms achieved a significantly greater improvement following treatment with the ToleroMune(R) T-cell vaccine than those on placebo (pless than or equal to0.05). The results were presented at the 2012 Annual...

2012-02-29 14:23:00

February Pollen Detection at Pittsburgh's Allegheny General Hospital is a First, Doctors Say PITTSBURGH, Feb. 29, 2012 /PRNewswire-USNewswire/ -- Tree pollen in the air in February? Unheard of - at least until now. The pollen detector on the roof of Allegheny General Hospital (AGH) in Pittsburgh has detected moderate amounts of tree pollen in February for the first time ever. Tree pollen normally arrives in April and is gone by Memorial Day. The last documented early tree pollen...

2011-12-22 10:49:00

GREENWOOD VILLAGE, Colo., Dec. 22, 2011 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NASDAQ: AMPE - News) ("Ampio" or the "Company"), a company that discovers and develops new uses for previously approved drugs and new molecular entities ("NMEs"), today announced notification of the granting of a Canadian patent with broad claims directed to: "METHOD OF USING DIKETOPIPERAZINES AND COMPOSITION CONTAINING THEM". The protected compositions contain either DA-DKP, a cyclic dipeptide...